Introduction
Although general anesthetics are used for approximately 21 million patients per year in the United States, 1 the molecular and cellular mechanisms by which anesthetics produce loss of waking consciousness are poorly understood. The complexity of consciousness and relatively imprecise clinical signs that are used to evaluate the depth of anesthesia are significant limitations for the study of consciousness. Recent advances in sleep neurobiology continue to enhance the understanding of different physiological traits that define altered states of consciousness. The original hypothesis 2 that neural networks that evolved to generate sleep are preferentially modulated by anesthetic drugs has been supported by multiple lines of evidence. [3] [4] [5] [6] [7] [8] [9] These data demonstrate that sleep neurobiology can contribute to understanding the mechanisms by which anesthetics cause loss of consciousness. The goal of this chapter is to selectively review the neurobiology of sleep and wakefulness in relation to anesthesia-induced loss of consciousness.
Neuronal and chemical substrates of sleep, wakefulness, and anesthesia

Sleep systems
In the early 1900s, the observation of localized injuries in the brains of patients that had suffered "encephalitis lethargica" led Constantine von Economo to propose that the anterior hypothalamus functions as a sleep center and the posterior hypothalamus functions as a wake center. 10 Possibly inspired by von Economo's observations, and based on his own brain transection studies (cerveau and encéphale isolé, reviewed in Steriade and McCarley 11 ), the neurophysiologist Frédéric Bremer postulated that sleep was a passive process resulting from the cessation of external sensory stimulation ("deafferentation"). Bremer's view, which was shared by most scientists at that time, was refuted less than two decades later by the seminal work of Moruzzi and Magoun describing the ascending reticular activating system (ARAS). 12 This and many other multidisciplinary studies have led to the widely accepted conclusion that sleep is actively generated by anatomically distributed and neurochemically diverse neural networks. Thus, the fields of both anesthesia and sleep neurobiology have matured beyond the adolescent wish for a sleep or anesthesia "center" and unitary mechanism of action. Major sleep-promoting brain nuclei and their projections are schematized in Figure 1 .1. www.cambridge.org © in this web service Cambridge University Press Cambridge University Press 978-0-521-51822-2 -Consciousness, Awareness, and Anesthesia Edited by George A. Mashour Excerpt More information
Brainstem nuclei and GABAergic transmission
Wakefulness-promoting neurons in the brainstem discharge at their highest rates during wakefulness, slow their firing rates during NREM sleep, and cease firing during REM sleep. Thus, these monoaminergic neurons are characterized by a wake-on, REM-off discharge profile. Many of these wake-on, REM-off neurons are tonically inhibited by GABAergic neurons that are thought to participate in the generation and maintenance of REM sleep. The subsections that follow describe brainstem nuclei for which there is evidence that GABAergic transmission contributes to REM sleep generation.
Laterodorsal and pedunculopontine tegmental (LDT-PPT) cholinergic neurons are phenotypically defined by the presence of the acetylcholine synthetic enzyme choline acetyltransferase. 28 GABAergic neurons in the LDT-PPT express c-Fos Propofol anesthesia eliminates the physiologic sleep rebound that follows sleep deprivation. 55 Rather than a sleeplike state occurring during general anesthesia, it is likely that the postanesthesia sleep drive is decreased, in part, by a reduction of extracellular levels of adenosine in sleep-promoting neurons. In agreement with this interpretation, basal forebrain or systemic administration of adenosine receptor antagonists partially reverses the potentiating effect of sleep deprivation on anesthetic-induced loss of righting reflex.
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A role for adenosine in generating and maintaining sleep and possibly anesthesia is strongly supported by the fact that the adenosine receptor antagonist caffeine is the most widely used wakefulness-promoting drug. The difficulty of elucidating cellular mechanisms generating sleep is illustrated in the next section, which shows that many of the brainstem nuclei containing sleep-active neurons also contain wake-active neurons.
Wakefulness-promoting systems
Moruzzi and Magoun demonstrated that the area encompassing the brainstem reticular formation generates cortical activation and behavioral arousal characteristic of wakefulness.
12 Sixty years of subsequent research has consistently supported the view that the reticular formation contributes to the regulation of sleep 11 and anesthesia. 5 The mesencephalic and rostral pontine portions of the reticular formation send projections to the forebrain via a dorsal pathway through the thalamus and a ventral pathway through the hypothalamus and basal forebrain. These ascending projections, which are presumably glutamatergic, activate thalamocortical and basalocortical systems. Reticulospinal projections from the caudal pons and medulla facilitate muscle tone during wakefulness. 57 Thalamocortical projections utilize glutamate as their neurotransmitter, whereas the main cortically projecting neurons from the basal forebrain use acetylcholine as their neurotransmitter. The brainstem reticular system known as the ARAS includes other wakefulnesspromoting cell groups localized to the pons, midbrain, and diencephalon. These wakefulness-promoting neurons are acetylcholine-containing cells in the LDT-PPT, norepinephrine-containing cells in the LC, serotonin-containing cells in the DRN, and dopamine-synthesizing neurons in the substantia nigra pars compacta and ventral tegmental area, and a population within the ventrolateral periaqueductal gray.
11 Although the mechanisms are unknown, GABAergic transmission in the oral part of the pontine reticular formation recently has been shown to be wakefulness promoting. In addition to the ARAS, acetylcholine-synthesizing neurons in the basal forebrain, histamine-containing cells in the posterior hypothalamus, and hypocretin-containing cells in the posterior lateral hypothalamus participate in the generation and maintenance of wakefulness. 11 The following sections present current evidence in the context of sleep neurobiology and anesthesia concerning some of the components of the wakefulness-promoting systems (Figure 1 .1).
Cholinergic neurons in the pontomesencephalic junction
Acetylcholine-containing neurons in the LDT-PPT send ascending projections to the forebrain and descending projections to diverse brainstem nuclei. 28 The LDT-PPT neurons generate cortical activation during wakefulness and during REM sleep via ascending projections to the thalamus and via the ventral extrathalamic pathway to the hypothalamus and basal forebrain. 58, 59 Descending projections from the LDT-PPT innervate several brainstem nuclei, including the pontine reticular formation, 60,61 and many lines of evidence support the conclusion that the www.cambridge.org © in this web service Cambridge University Press Dexmedetomidine is a selective alpha-2 adrenoceptor agonist used for shortterm sedation. Dexmedetomidine inhibits LC neurons leading to the proposal that the sedative actions of dexmedetomidine involve inhibition of LC neurons and disinhibition of VLPO neurons in the hypothalamus.
7 Clinical data also support the view that norepinephrine and the LC contribute to regulating states of consciousness. There is evidence that a possible mechanism underlying the high incidence of emergence agitation produced in human patients by sevoflurane may be due to the excitatory effect of sevoflurane on LC neurons. 
